Most impressed with the way Dermott is implementing his strategy for commercialisation. I still feel that the UN and aid market is the most important hurdle for the company to navigate, not sure how political UN and private spends are to get the unit price down.
- Forums
- ASX - By Stock
- trial update and 100% distribution rights
Most impressed with the way Dermott is implementing his strategy...
Featured News
Add EMS (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.818M |
Open | High | Low | Value | Volume |
1.6¢ | 1.7¢ | 1.6¢ | $8.454K | 513.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 339631 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 58881 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 339631 | 0.016 |
2 | 201499 | 0.014 |
4 | 354692 | 0.013 |
3 | 291753 | 0.012 |
2 | 119999 | 0.011 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 58881 | 1 |
0.018 | 280333 | 1 |
0.020 | 353727 | 4 |
0.023 | 313043 | 1 |
0.024 | 70000 | 1 |
Last trade - 15.58pm 15/11/2024 (20 minute delay) ? |
Featured News
EMS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online